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ST-Segment Elevation
Myocardial Infarction
I would like to congratulate the authors for their paper in the
mini-focus issue on the ST-segment elevation myocardial infarc-
tion (STEMI) (1), for calling attention to the fact that door-to-
balloon time might not be the best metric to assess successful
treatment of STEMI (2). In their State-of-the-Art paper, the
authors clearly point out that measuring door-to-balloon time
ignores, for the most part, the pre-hospital phase of myocardial
infarction. In the piece that I wrote for Clinical Cardiology, I made
the point that door-to-balloon time is certainly a-metric (i.e., easy
to measure and can be documented accurately). Unfortunately, in
the human it is nearly impossible to measure the precise onset of
occlusion of a coronary artery. Many patients can present with
stuttering chest pain for many hours before arriving in the
emergency department, at which time that is the first indication of
ST-segment elevation, and that is when door-to-balloon time is
calculated.
There is no question that door-to-balloon time has been studied
carefully and correlates well with successful outcomes. However, it
does not take into account several factors that might influence the
outcome positively or negatively. It seems to me that attention to
details of the individual parameters noted before, during, and after
percutaneous coronary intervention in STEMI patients might
make a difference in outcome and should be considered when
metrics of successful management of acute STEMI are being
considered by oversight or regulatory bodies.
There are several clinical conditions that might influence
outcome. For example:
Patients who have had a previous infarction might have a worse
outcome than patients who present with a first infarction.
If chronic angina was present before STEMI, outcome might
be better, because collaterals might be present.
If the patient was diabetic and not well-controlled, outcome
might be poorer than a patient who is not diabetic.
If the patient was markedly hypertensive, outcome might be
poorer than if the patient was normotensive or well-
controlled with drugs.
If the patient had chronic obstructive pulmonary disease,
outcome might be poorer than if the patient had normal
lung function.
ll these parameters, as far as I can tell, have not really been
ddressed in the classic articles on door-to-balloon time in patients
resenting with STEMI.
Thus, I share the belief (and evidence) of the authors that
ortality is strongly correlated with total ischemic time. However,
also would add other factors that might contribute to mortality that are not really counted when the only metric measured is
oor-to-balloon time.
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Reply
We appreciate the comments of Dr. Conti on our paper (1). We
agree with Dr. Conti that the door-to-balloon (DTB) time is a
well-established and well-studied measure in myocardial infarc-
tion. It is our opinion, however, that this measure fails to take into
account the period before the patients present to the hospital. We
also seem to have reached a plateau in terms of getting any further
benefit by additional shortening of the DTB time. As reported by
Flynn et al. (2), the DTB has declined in Michigan each year, from
113 minutes in 2003 to 76 min in 2008, but the mortality rate
failed to follow this decrease. The in-hospital mortality was 4.1%
in 2003 and 3.62% in 2008 (p  0.69). Similarly, in 43,678
atients with acute myocardial infarction in the United States
valuated from 2005 to 2007, although the DTB time decreased
rom 101 to 87 min, the mortality did not change (3). Indeed, as
tated in our paper, the true window for infarct salvage is ideally
ess that 2 h of ischemic time. Typically, the “door time” in much
f the world is well beyond 2 h after start of symptoms, which
xplains why there is little-to-no correlation with improvements in
TB time and improvements in mortality.
Dr. Conti states that it is difficult to determine the onset of
ymptoms. We would suggest that although this is true of some
atients, many patients are able to accurately report when their
ymptoms started. When DTB first began to be tracked, certain
hanges in data collection were made, such as arrival times and
eparture times, which then required efforts to synchronize clocks
n emergency departments and catheterization laboratories, and so
orth: efforts that are still incomplete. When and if we start
racking the true ischemic times, emergency responders and
hysicians will become more alert to the symptom onset as a
aluable time to record. Thus, the estimation of the true ischemic
ime will become easier.
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Letters to the Editor1052The factors suggested by Dr. Conti that influence the outcome
of the patients with ST-segment myocardial infarction are all valid.
Unfortunately, they are not adequately addressed in the trials
where influence of DTB time on outcomes has been studied.
Our goal in treating myocardial infarction should be both to
decrease mortality and preserve left ventricular function (prevent
the development of heart failure). Because the time from symptom
onset to reperfusion has been shown to decrease infarct size, it is
only natural now to target it as representative of the total ischemic
time. We should start measuring it routinely.
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Out-of-Hospital Cardiac Arrest
Patients With ST-Segment
Elevation on Electrocardiogram
Don’t Rush Patients for Emergent
Percutaneous Coronary Intervention in the
Era of Aggressive Door-to-Balloon Time
As an institution that has a great interest in and has studied cardiac
arrest and ST-segment elevation myocardial infarction (STEMI)
(1), we read with great interest and agree with Dr. Kern (2) that we
should provide “operators and medical centers the opportunity to
do what is best for the individual STEMI patient, without fear of
unfair inflation of their overall reported mortality figures.”
We agree that “such a change cannot come too soon” for those
cardiac arrest STEMI victims comatose on arrival to the hospital.However, we now fear that with aggressive door-to-balloon-time
initiatives and our prior report on STEMI and out of hospital
cardiac arrest (OHCA), that operators are performing emergent
percutaneous coronary intervention (PCI) too often in comatose
patients when STEMI does not in fact truly exist.
A recent abstract from our institution by Abraham et al. (3),
presented at the most recent American College of Cardiology
Scientific Sessions, noted that aggressive catheterization was per-
formed in patients with noncardiac causes of ST-segment elevation
on electrocardiogram. Many of these patients had OHCA and the
catheterization delayed the diagnosis and treatment of the primary
etiology. Subsequent work-up showed that the cause of mortality
was varied and included sepsis, hyperkalemia, intracranial hemor-
rhage, aortic dissection, left ventricular aneurysm, and pulmonary
embolism.
We are now victims of our own success in that we had
concluded in 2009 that “resuscitated patients with STEMI in the
ED should be seriously considered for emergent revascularization
regardless of neurologic status. These patients should be treated
with the same urgency as patients with acute STEMI without
cardiac arrest (1).”
We agree with Dr. Kern and advocate aggressive evaluation and
treatment of comatose OHCA patients found to have diagnostic
STEMI with emergent PCI and therapeutic hypothermia. How-
ever, we emphasize not to push every arrest patient to the
catheterization laboratory without appropriate evaluation in the
emergency department to ensure coronary obstruction as an
etiology for the event. Not infrequently, these ST-segment
changes are concurrent with another catastrophic event that leads
to ischemic changes on the electrocardiogram.
Though, the mantra has always been “time is myocardium,” a
5-min delay in door-to-balloon time to practice sound clinical
medicine is unlikely to cause higher mortality and morbidity.
However, delaying treatment of the true etiology of arrest by
performing emergent catheterization may, in fact, do so.
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